Tag: Dr. Richard Warner

FDA Approves Novel Radio-peptide Targeted Therapy Clinical Trial for Neuroendocrine Cancer: PRRT (Peptide Receptor Radionuclide Therapy)

For the first time in North America, neuroendocrine cancer patients will have the opportunity to participate in a clinical trial of Lutetieum-177 (LU-177)with Octreotate. Ebrahim S. Delpassand, MD, chief executive officer and medical director of…

Study to Evaluate Families with History of Carcinoid Cancer

The Natural History of Familial Carcinoid Tumor is recruiting participants who are interested in being part of a study that will “evaluate families with a history of carcinoid cancer to determine ways to improve early detection and to find the gene that…

Carcinoid & Neuroendocrine Cancer Conference Presented by CCAN Now Online

If you missed the carcinoid and NET conference presented by the Carcinoid Cancer Awareness Network in November, you can now view it online.  And if you want to hear some great presentations again, click here.

The guest speakers and their presentations …

Clinical Trial Recruiting Neuroendocrine Tumor Patients with Pheochromocytoma or Paraganglioma

Neuroendocrine tumor patients with malignant pheochromocytoma or paraganglioma are being sought for a multi-center clinical trial conducted by Molecular Insight Pharmaceuticals, Inc. In the New York area, one of the clinical trial sites is the Mount…

Vancouver Carcinoid & Neuroendocrine Tumor Conference Program Now Online

The program for the Carcinoid Neuroendocrine International Conference and Symposium for Medical Professionals and Patients to be held in Vancouver, Canada from May 13 to May 16 is now available online at: http://www.cnetscanada.org/

The conference…

Carcinoid Cancer and Neuroendocrine Tumor Patients: Where Do I Start?

There are so many questions when you are newly diagnosed with carcinoid cancer or another neuroendocrine tumor.  Where do I start to learn more about these rare cancers?  When patients or their families call the support and information line at the Carcinoid…